A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats-Reference-Cited by-同舟云学术

A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats

Published:2005-04-18 Issue:1 Volume:314 Page:410-421
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Honore Prisca,Wismer Carol T.,Mikusa Joe,Zhu Chang Z.,Zhong Chengmin,Gauvin Donna M.,Gomtsyan Arthur,El Kouhen Rachid,Lee Chih-Hung,Marsh Kennan,Sullivan James P.,Faltynek Connie R.,Jarvis Michael F.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference44 articles.

1. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists

2. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border.

3. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

4. Osteoclastic Bone Resorption by a Polarized Vacuolar Proton Pump

5. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRPV1 Channels in the Central Nervous System as Drug Targets;Pharmaceuticals;2024-06-07

2. TRPV1: Receptor structure, activation, modulation and role in neuro-immune interactions and pain;Cell Calcium;2024-05

3. Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis;Cell Proliferation;2023-11-23

4. The Function and Gating Mechanism of TRPV1 Channel and The Application of Its Modulators in Drug Research and Development;PROG BIOCHEM BIOPHYS;2023

5. In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity;Pharmaceutics;2022-11-22